tiprankstipranks
Omeros Corp (OMER)
NASDAQ:OMER
US Market
OMER
Omeros
RESEARCH TOOLSreports
Want to see OMER full AI Analyst Report?

Omeros (OMER) Stock News & Sentiment

830 Followers
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
Premium
Company Announcements
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
27d ago
OMER
Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
2M ago
OMER
Omeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target
Premium
Ratings
Omeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target
2M ago
OMER
Balanced Risk/Reward and Gradual Yartemlea Ramp Justify Hold Rating on Omeros
Premium
Ratings
Balanced Risk/Reward and Gradual Yartemlea Ramp Justify Hold Rating on Omeros
4M ago
OMER
Omeros: YARTEMLEA Approval and Novo Nordisk Partnership Drive Re‑Rating Potential and Support Buy Rating
Premium
Ratings
Omeros: YARTEMLEA Approval and Novo Nordisk Partnership Drive Re‑Rating Potential and Support Buy Rating
4M ago
OMER
Omeros Completes Major Asset Deal with Novo Nordisk
Premium
Company Announcements
Omeros Completes Major Asset Deal with Novo Nordisk
5M ago
8K
OMER
Omeros Corporation’s Earnings Call Highlights Strategic Moves
Premium
Company Announcements
Omeros Corporation’s Earnings Call Highlights Strategic Moves
5M ago
OMER
More OMER News >

OMER News on the Web

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
TipRanks News
Neutral
Permanent J-Code Assignment for YARTEMLEA Signals Improved Access and Streamlined Reimbursement for Omeros
Market Chameleon
Neutral
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
Zacks
Bullish
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), PepGen Inc. (PEPG) and Omeros (OMER)
TipRanks News
Neutral
Omeros Delivers Fourth Quarter Profit and Clears Major Debt with Novo Nordisk Deal: What’s Next After FDA Approval of YARTEMLEA?
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and Agios Pharma (AGIO)
TipRanks News
Bullish
Novo Nordisk Deal Transforms Omeros Financials as YARTEMLEA Launch Gains Traction
Market Chameleon
Bullish

News Score - Last 7 Days

Neutral
OMER
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OMER’s Media Buzz Sentiment?
2 articles about OMER were published this week. In an average week, 3 articles are published.
    What is OMER’s weekly average amount of articles?
    In an average week, 3 articles about OMER are published.
      What is OMER’s News Sentiment?
      50% of articles about OMER were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week